Phillip Mertz
Directeur/Bestuurslid bij ALPHA COGNITION INC.
Vermogen: 754 749 $ op 31-05-2024
Actieve functies van Phillip Mertz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALPHA COGNITION INC. | Directeur/Bestuurslid | 22-03-2021 | - |
Loopbaan van Phillip Mertz
Eerdere bekende functies van Phillip Mertz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - | - |
Opleiding van Phillip Mertz
| Harvard University | Undergraduate Degree |
Statistieken
Internationaal
| Canada | 3 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 3 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Phillip Mertz
- Ervaring
